Celanese Announces Plasticizer WVC 3800 Price Increases in Europe and Asia

DALLAS & AMSTERDAM & SHANGHAI--(BUSINESS WIRE)-- Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will increase list and off-list selling prices for Plasticizer WVC 3800 (3G8) in Europe and Asia. The price increases below will be effective immediately, or as contracts otherwise allow.

About Celanese

Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our two complementary business cores, Acetyl Chain and Materials Solutions, use the full breadth of Celanese's global chemistry, technology and business expertise to create value for our customers and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese currently employs approximately 7,500 employees worldwide and had 2016 net sales of $5.4 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.

All registered trademarks are owned by Celanese International Corporation or its affiliates.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170626005651/en/

Celanese Corporation
Investor Relations
Surabhi Varshney, +1-972-443-3078
[email protected]
or
Media Relations – Global
W. Travis Jacobsen, +1-972-443-3750
[email protected]
or
Media Relations Asia (Shanghai)
Helen Zhang, +86 21 3861 9279
[email protected]
or
Media Relations Europe (Germany)
Jens Kurth, +49(0)69 45009 1574
[email protected]

Source: Celanese Corporation

You May Also Be Interested In

• Celanese raises prices on select engineered materials in Asia, EMEA
• One Payment Plan Advocates for a More Human Approach to Debt Relief As Americans Face Financial Pressure
• Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care